Prostate Vaccine

Featured Article

Provenge, an experimental vaccine to treat advanced prostate cancer, "significantly prolonged" men's lives in a recent clinical trial, drugmaker Dendreon reports. The company did not reveal the results of the trial of 512 men, saying they would be given at a Urology conference in late April. These results are a follow-up to the U.S. Food and Drug Administration's 2007 request to see long-term data on the safety and effectiveness of Provenge before final approval. 

Read more

More information on "Prostate Vaccine"

From Our Experts

See more SharePosts »

From Our Sources

More on Prostate »